Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - PROTECT PHARMACEUTICAL Corpv243857_ex99-1.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported):   December 23, 2011

PROTECT PHARMACEUTICAL CORPORTION
(Exact name of registrant as specified in its charter)
 
NEVADA 000-54001 27-1877179
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
 
116m Village Boulevard, Suite 200, Princeton, New Jersey 08540
(Address of principal executive offices)

Registrant's telephone number, including area code:                                                                                     609-945-1198

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 

 
FORM 8-K

Item 5.02   Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Mr. Dipak Chattaraj has resigned as a director of Protect Pharmaceutical Corporation, Effective December 14, 2010.  Mr. Chattaraj stated in his letter to the Board that because of Owing to other preoccupations, he would not be able to serve on Protect board. No replacement for Mr Chattaraj has been named as of this date.

Notes about Forward-looking Statements

Statements contained in this current report which are not historical facts, may be considered "forward-looking statements," which term is defined by the Private Securities Litigation Reform Act of 1995.  Forward-looking statements are based on current expectations and the current economic environment.  We caution readers that such forward-looking statements are not guarantees of future performance. Unknown risks and uncertainties as well as other uncontrollable or unknown factors could cause actual results to materially differ from the results, performance or expectations expressed or implied by such forward-looking statements.

Item 9.01                 Financial Statements and Exhibits

(c) Exhibits
 
Exhibit No.   Description
     
99.1   Email from Dipak Chattaraj dated December 13, 2011
______________


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  TRANS ENERGY, INC.  
       
Date:   December 22, 2011
By:
/S/ Ramesha Sesha
 
    Ramesha Sesha  
    Chief Executive Officer  
 
 
-2-